Forte Biosciences Q1 2026 Earnings Prerevenue Biotech Misses EPS Estimates Stock Dips on Narrower Loss Miss DEC Q2 2024 Earnings EPS Surges 83 Above Estimates Amid Revenue Uncertainty SCI Q1 2026 Earnings EPS Misses Estimates Despite Stable Operations ORLY Q1 2026 Earnings EPS Beat Provides Mixed Sentiment Amid Broader Market Pullback SSSSL Q1 2026 Earnings Stellar EPS Surprise Driven by Strong Investment Gains NCTY Q1 2012 Earnings Narrower Loss Beats Estimates as Company Restructures